Return to the catalog
IGF-1 LR3
NewOut of stock1mg vial

IGF-1 LR3

Long-acting version of insulin-like growth factor 1, studied for muscle cell growth and repair.

For Research Use Only

Sold strictly for laboratory research. Not for human or veterinary use, ingestion, or clinical/diagnostic application.

Pricing coming soon

Contact us for a quote on this batch.

Bacteriostatic water included

99%+ Purity
Extensively Researched

About this peptide

IGF-1 LR3 is a modified form of IGF-1 — the hormone the liver releases in response to growth hormone, and the one that actually tells muscle and other tissues to grow. Two changes (an extra 13-amino-acid tail and one swapped amino acid) stop it from being locked up by binding proteins in the blood, so it stays active far longer than natural IGF-1. Researchers use it widely in cell culture and muscle-growth studies.

Why researchers reach for IGF-1 LR3

Muscle-growth research

Studied for driving muscle-cell growth and the formation of new muscle fibres in laboratory models.

Extended activity

Resists binding proteins, giving a much longer active window than natural IGF-1 — useful for consistent experimental exposure.

Cell proliferation standard

A widely used growth supplement in cell-culture and bioprocessing research.

Key features

  • 98%+ purity verified by HPLC
  • 83-amino-acid IGF-1 analogue
  • Lyophilised powder for stability
  • 1 mg research vial
  • Bacteriostatic water included
  • For laboratory research use only

How it works

IGF-1 receptor activation

Binds the IGF-1 receptor and switches on the PI3K/Akt and MAPK pathways that drive cell growth and survival.

Reduced binding-protein capture

The Arg3 substitution and N-terminal extension cut binding to IGFBPs, leaving more free, active peptide.

Satellite-cell signalling

Studied for activating muscle stem (satellite) cells involved in repair and hypertrophy.

Research dosage guidelines

Reference ranges only — reproduced from published preclinical literature. Not a recommendation for human use.

RangeReported doseNote
Reported research range20–100 mcgPer administration in research protocols; no human clinical dosing has been published for the LR3 analogue.
Frequency1× dailyProtocols describe short cycles of around 4 weeks.
Typical reconstitution2 mL bacteriostatic waterYields 0.5 mg/mL (500 mcg/mL).

Tracking this compound? Registered researchers can log active IGF-1 LR3 protocols in their private Research Log.

Timing in research protocols

No human timing data — evidence is cell-culture and animal only.

  • The LR3 analogue has not been through human clinical trials, so no clock time, meal relationship or cycle length is established.

Drawn from published research protocols and pharmacology literature. Reference information for laboratory research only — not an instruction or guidance for use.

Technical specifications

Scientific name
Long Arg3 insulin-like growth factor-1 (LR3-IGF-1)
Sequence
MFPAMPLSSLFVN + [Arg3]IGF-1 (83 amino acids)
CAS number
946870-92-4
Molecular weight
~9111 Da
Purity
98%+ (HPLC)
Form
Lyophilised white powder
Vial size
1 mg
Reconstitution
2 ml bacteriostatic water
Storage (unopened)
-20 degrees C, protected from light
Storage (reconstituted)
2-8 degrees C, use within 30 days

Published research

Peer-reviewed literature on IGF-1 LR3. Links open in a new tab.

Research use notice

IGF-1 LR3 is supplied strictly for laboratory research. No human clinical dosing protocols exist for this analogue. Not for human or veterinary use, ingestion, or clinical application.

#igf-1-lr3#igf-1#muscle-growth#growth-factor#gh-axis

Cart (0)

Your cart is empty